INFINITY PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
INFINITY PHARMACEUTICALS, INC. has filed 1,187 SEC EDGAR filings since 09 May 2000

SEC filing history

Showing 326-350 of 745 matching filings.

Per page
25
Current page
14
8-K File 000-31141

FORM 8-K

Filing date
09 Aug 2016
Reporting date
09 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
29 Jul 2016
Reporting date
22 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

FORM 8-K

Filing date
26 Jul 2016
Reporting date
25 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60943

INIFINITY 13GA AMEND 4

Filing date
11 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

8-K

Filing date
28 Jun 2016
Reporting date
24 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60943

THE SCHEDULE 13G

Filing date
24 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

8-K

Filing date
22 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-209661

424B5

Filing date
04 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2016
Reporting date
02 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 May 2016
Reporting date
02 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-209661

EFFECT filing

Filing date
28 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-31141

DEF 14A

Filing date
25 Apr 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31141

8-K

Filing date
11 Apr 2016
Reporting date
08 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .